23andMe: a clinical trial for Immuno-oncology Antibody
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”)…
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”)…
Gartner just recently introduced their top strategic technology trends for 2022. Th…
Sensors based on 4D imaging radar can instantly identify falls, and prompt Alexa to…
Vinehealth, a 2018-founded, London-based digital health startup that’s built an app…
Launched in October for Breast Cancer Prevention Month, WHO's interactive chatbot t…
BOSTON – December 3, 2021 – Pear Therapeutics, Inc. (“Pear Therapeutics”), the…
PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administra…
Pear Therapeutics, Inc., the leader in developing and commercializing software-base…
Research Highlights: A novel software algorithm developed for wearable devices, …
In the IASP 2021 Virtual World Congress of Pain, the results from Orion Corporation…